Widely read:
Anand Kumar/AI-Generated Image
Summary: Jyothy Labs still has strong brands, a deep distribution network and a debt-free balance sheet, but the loss of its Pril licence has exposed how much of its earlier growth was built on a brand it did not own. Investors now need to separate the company’s durable moat from its borrowed growth.
Around two years back, Jyothy Labs was the apple of the eye for quality investors: a debt-free, promoter-run FMCG company with market-leading brands. However, this came crashing down post September 2024, when the stock, after reaching an all-time high of Rs 595, started going downhill. Since then, its share price fell over 60 per cent from that peak.
The trigger? In May 2026, Henkel, the German company that helped Jyothy Labs build one of its most profitable labs, told the latter that it wouldn’t be renewing its licence beyond the end of the month. However, there’s more to the story. It’s about how much of Jyothy’s moat was borrowed and what is left once the borrowed part leaves.
A blue-bottle empire
Jyothy Labs was founded in 1983 by M P Ramachandran, who created the popular ‘Ujala’ fabric whitener into a household name across India. The company expanded rapidly in 2011, when it acquired Henkel’s India consumer business. This deal came in three layers: brands such as Margo and Chek were brought, while others like Henko and Mr White came with lifetime licences and two others, Pril and Fa, were licensed for a 15-year term. Henkel retained global ownership of these brands.
Today, Jyothy sells across fabric care, dishwashing, household insecticides and personal care, reaching close to four million outlets, of which 1.4 million are served directly, through 23 manufacturing plants. Ujala Supreme has led the fabric whitener category since its launch four decades ago; Exo Dishwash Bar ranks second in the dishwash category by value; Maxo is the second-largest mosquito repellent coil by volume. The company carries no debt and sits on a cash pile approaching Rs 1,000 crore as of FY26.
Financial snapshot, FY22-26
Jyothy Labs has reported slow, yet consistent growth
| Particulars | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Operating revenue (Rs crore) | 2,196 | 2,486 | 2,757 | 2,847 | 2,944 |
| EBITDA (Rs crore) | 248 | 316 | 480 | 500 | 450 |
| EBIT margin (%) | 8.7 | 10.7 | 15.6 | 15.6 | 13.2 |
| Net profit (Rs crore) | 159 | 240 | 369 | 370 | 333 |
| Return on equity (%) | 11.1 | 16 | 22 | 19.2 | 22.5 |
Decades in the making
A moat like that of Jyothy Labs isn't built in two or three years. Ujala earned its fabric-whitener leadership over four decades of brand investment, rather than a one-off good stretch. The 2011 Henkel deal compressed years of category-building into a single transaction, handing Jyothy instant scale in dishwashing and personal care. From FY11 till FY25, Jyothy Labs compounded its revenue and net profit annually by 11 per cent and 13 per cent, respectively.
Segment-wise revenue share
Fabric care and dishwashing dominate Jyothy Labs’ revenue pie
| Segment | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Fabric care | 42% | 43% | 44% | 46% |
| Dishwashing | 35% | 34% | 34% | 32% |
| Household insecticides | 9% | 8% | 7% | 7% |
| Personal care | 10% | 11% | 11% | 11% |
| Others | 4% | 4% | 4% | 4% |
Even within these good years, one segment never quite joined the party: household insecticides. This segment has posted a loss every year through FY26, driven by a structural decline in coils, the format Jyothy has traditionally led. The losses narrowed sharply in FY26, helped by a shift in mix toward liquid vaporisers and newer formats, a repositioning management credits with moving the segment closer to profitability, even as revenue kept shrinking.
So what went wrong?
The story turned over the last two years. Crude-linked input costs rose sharply through the year, and Jyothy chose to absorb part of that pressure rather than cut brand spending, pulling the EBIT margin down from 15.6 to 13.2 per cent even as revenue kept growing. Competitive intensity rose too, with regional brands, quick commerce and private labels chipping away at traditional distribution models.
Then came the June 2026 quarter. Excluding Pril and Fa, underlying revenue grew a healthy 8.1 per cent in value terms. Including them, reported revenue growth crawled to just 3 per cent, operating margin nearly halved year on year and profit fell by roughly half. The gap between those two numbers is the clearest evidence yet of how much weight one licensed brand was carrying.
A borrowed brand
Dishwashing was Jyothy's second-largest segment and, within it, Pril anchored the fast-growing liquid category, a franchise built over 15 years of Jyothy's own advertising and distribution spend. But Pril was never Jyothy's brand to keep. When Henkel decided not to renew the licence beyond May 31, 2026, the franchise reverted to Henkel by contract, not because of any failure in Jyothy's execution.
Jyothy has since gone to court to contest the exit terms. In the meantime, the company's stated plan is to push Exo, its own dishwash brand and the number two player in the category by value, into the liquid format, a segment Exo has technically been present in for years without ever building real scale.
Real moat or rented?
Judged by the standards a long-term investor would apply, Jyothy's moat splits cleanly into two parts. The first is genuinely durable: four decades of category leadership in fabric whitener, a distribution network reaching four million outlets that took years to build, brand equity in Ujala, Margo, Maxo and Henko, carrying none of the expiry risk that undid Pril and Fa.
The second part is the one investors were really paying up for through 2023 and 2024: the margin expansion and premiumisation story in dishwashing, and it leaned heavily on a brand Jyothy never owned. Fifteen years of building a licensed brand is real, valuable work, but it does not carry the same durability as a brand you hold outright; the owner can, and in this case did, walk away.
The bottom line
Management is guiding for double-digit revenue growth for FY27, excluding Pril and Fa, with margin recovery expected to be gradual and back-loaded into the second half. The debt-free balance sheet and cash pile give the company real room to fund the Exo push without straining itself, and the board has kept the dividend steady even as profit fell.
The stock now trades at 27 times earnings, well below its five-year median of 35 times, but the earnings base itself carries more uncertainty today than it did then, given the transition underway in dishwashing and the unresolved litigation. For anyone assessing this business now, the more useful exercise isn't asking whether Jyothy Labs has lost its shine, but separating which parts of that shine it actually owned in the first place, and building a view of the moat and the price from there.
Want to know if a stock's moat is as strong as it looks?
Value Research Stock Advisor helps you dig past the headline numbers, separating durable competitive advantages from borrowed or rented ones, so you can judge whether a company's growth story (and its valuation) is built to last. Get in-depth analysis, moat assessments and insights into past financials in stocks like Jyothy Labs.
Subscribe to Stock Advisor today
Ask Value Research 
New episodes every Friday 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
